Dna X (SONM) Equity Average (2018 - 2025)
Dna X (SONM) has disclosed Equity Average for 8 consecutive years, with -$1.0 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Equity Average fell 106.2% year-over-year to -$1.0 million, compared with a TTM value of -$1.0 million through Sep 2025, down 106.2%, and an annual FY2024 reading of $8.3 million, down 60.7% over the prior year.
- Equity Average was -$1.0 million for Q3 2025 at Dna X, up from -$1.2 million in the prior quarter.
- Across five years, Equity Average topped out at $23.9 million in Q1 2021 and bottomed at -$3.4 million in Q1 2025.
- Average Equity Average over 5 years is $14.1 million, with a median of $16.2 million recorded in 2021.
- The sharpest move saw Equity Average skyrocketed 134.79% in 2023, then crashed 116.06% in 2025.
- Year by year, Equity Average stood at $15.6 million in 2021, then surged by 30.19% to $20.4 million in 2022, then increased by 11.7% to $22.7 million in 2023, then plummeted by 78.78% to $4.8 million in 2024, then tumbled by 121.09% to -$1.0 million in 2025.
- Business Quant data shows Equity Average for SONM at -$1.0 million in Q3 2025, -$1.2 million in Q2 2025, and -$3.4 million in Q1 2025.